EUVIMEDEUVIMED entdecken
Crossref

Clinical Impact of Persistent Microvascular Obstruction in CMR After Reperfused STEMI

Felix Troger iD, Mathias Pamminger iD, Paulina Poskaite iD, Martin Reindl iD, Magdalena Holzknecht iD, Ivan Lechner iD, Christina Tiller iD, Sebastian von der Emde, Alex Kaser iD, Fritz Oberhollenzer iD, Matthias Schwab, Benjamin Henninger iD und 3 weitere

Circulation: Cardiovascular Imaging · 2025-06 · 18 (6)

DOI: 10.1161/circimaging.124.017645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Imaging, 2025-06. Verfasst von Felix Troger und 14 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic of Radiology, Medical University of Innsbruck, Austria (F.T., M.P., P.P., M.S., B.H., A.M.). Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Microcirculation, Magnetic Resonance Imaging, Cine, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Microvascular injury in the course of acute ST-segment–elevation myocardial infarction (STEMI) has been identified as determinant of adverse outcomes and manifests as microvascular obstruction (MVO). MVO has long been regarded as a transient finding, vanishing within a few weeks after infarction. However, recent studies have shown that it may persist beyond the early phase, resulting in adverse remodeling. However, its clinical implications remain unclear. This study aims to evaluate the association of MVO persistence and major adverse cardiac events after STEMI. METHODS: In total, 609 patients with revascularized first-time STEMI underwent cardiac magnetic resonance imaging (CMR) at 4 days, 4 months, and 12 months after STEMI to assess MVO, infarct size, and left ventricular function. Major adverse cardiac events were defined as composite of death, reinfarction, and new congestive heart failure within a median interval of 3.2 years. RESULTS: Baseline MVO was present in 365 (60%) patients and persisted in 35 (10%) patients at 4-month CMR and in 20 (5%) patients at 12-month CMR. Compared with transient MVO not present at follow-up, patients with MVO persistence ≥4 months were more likely to experience major adverse cardiac events during follow-up (29% versus 13%; P =0.016). Within patients with MVO, those with MVO persistence had lower left ventricular ejection fraction ( P =0.002), larger infarcts ( P =0.00001), and more frequent intramyocardial hemorrhage ( P =0.001) at baseline CMR. CONCLUSIONS: Persistent MVO after STEMI occurs in up to 10% of patients with baseline MVO and is linked to major adverse cardiac events. Patients with MVO persistence had larger infarcts, lower left ventricular function, and more frequent intramyocardial hemorrhage at baseline CMR. All patients with MVO persisting ≥12 months initially showed intramyocardial hemorrhage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ST Elevation Myocardial InfarctionMicrocirculationMagnetic Resonance Imaging, CinePercutaneous Coronary InterventionCoronary CirculationHumansFemaleMaleMiddle AgedAgedVentricular Function, LeftTime FactorsTreatment OutcomePredictive Value of TestsRisk FactorsStroke VolumeVentricular Remodeling

Stichwörter der Autor:innen

heart failuremyocardial infarctionstroke volumeventricular function, left

Autor:innen und Institutionen

  • University Clinic of Radiology, Medical University of Innsbruck, Austria (F.T., M.P., P.P., M.S., B.H., A.M.).
  • University Clinic of Internal Medicine III, Medical University of Innsbruck, Austria (M.R., M.H., I.L., C.T., S.v.d.E., A.K., F.O., B.M., S.J.R.).

ORCID-Profile: Felix Troger, Mathias Pamminger, Paulina Poskaite, Martin Reindl, Magdalena Holzknecht, Ivan Lechner, Christina Tiller, Alex Kaser, Fritz Oberhollenzer, Benjamin Henninger, Bernhard Metzler, Sebastian J Reinstadler, Agnes Mayr

Zitieren

APA

Troger, F., Pamminger, M., Poskaite, P., Reindl, M., Holzknecht, M., Lechner, I., Tiller, C., von der Emde, S., Kaser, A., Oberhollenzer, F., Schwab, M., Henninger, B., Metzler, B., Reinstadler, S. J., & Mayr, A. (2025). Clinical Impact of Persistent Microvascular Obstruction in CMR After Reperfused STEMI. Circulation: Cardiovascular Imaging, 18(6). https://doi.org/10.1161/circimaging.124.017645

Vancouver

Troger F, Pamminger M, Poskaite P, Reindl M, Holzknecht M, Lechner I, et al. Clinical Impact of Persistent Microvascular Obstruction in CMR After Reperfused STEMI. Circulation: Cardiovascular Imaging. 2025;18(6). doi:10.1161/circimaging.124.017645

BibTeX
@article{Troger2025,
  author = {Troger, Felix and Pamminger, Mathias and Poskaite, Paulina and Reindl, Martin and Holzknecht, Magdalena and Lechner, Ivan and Tiller, Christina and von der Emde, Sebastian and Kaser, Alex and Oberhollenzer, Fritz and Schwab, Matthias and Henninger, Benjamin and Metzler, Bernhard and Reinstadler, Sebastian J and Mayr, Agnes},
  title = {Clinical Impact of Persistent Microvascular Obstruction in CMR After Reperfused STEMI},
  journal = {Circulation: Cardiovascular Imaging},
  year = {2025},
  volume = {18},
  number = {6},
  doi = {10.1161/circimaging.124.017645}
}
Kostenlos starten →